Nvidia Partners with Bristol Myers, Nebius for AI Advancements

Nvidia partners with Bristol Myers Squibb to build an AI factory for drug discovery. A partnership between Nvidia and Palantir aims to help government agencies build secure AI systems. Nvidia also disclosed a 9.3% stake in Nebius.

Nvidia Corporation has partnered with Bristol Myers Squibb to develop an AI factory for drug discovery. This marks a significant investment in expanding the potential for drug development through artificial intelligence .

In other news, Nvidia has expanded its AI growth strategy with a new partnership with Palantir to assist government agencies in building secure, sovereign AI systems .

Further, Nvidia announced a notable investment by acquiring a 9.3% stake in Nebius , contributing to a significant increase in Nebius stock.

Bristol Myers Squibb is also using Nvidia technology to enhance its AI infrastructure for drug discovery, aiming to significantly boost capacity.